Skip to content
Open access

Methodologies for Manipulating Cardiomyocyte Physiology: In Vitro and In Vivo Perspectives

Aug 2026 · bioRxiv · 0 citations · 45 references
Biology

TL;DR

This study provides comprehensive methodologies for studying cardiomyocyte physiology and manipulating heart rates in vitro and in vivo with video-based Short-Time Fourier transformation method.

Abstract

Cardiac tissue is primarily made up of cardiomyocytes, which are regulated by the autonomic nervous system. We have used and developed approaches such as patch clamping and electrical stimulation-combined calcium imaging, computer modeling, optogenetics and chemogenetics combining with video-based Short-Time Fourier transformation (STFT) method to study the physiological activities of cardiomyocytes. The action potential of cardiomyocytes was found to be synchronized with calcium signals, which can be grouped into two categories by STFT. A mathematical model was developed to simulate the changes in electrical activities within cardiomyocytes caused by energy depletion, especially for 2-deoxy-D-glucose (2DG) treatment. Optogenetic and chemogenetics tools, such as ChR2(H134R), OptoXR-β2AR and hM3Dq accelerated beating, while GR, ACR1 and hM4Di inhibited cardiomyocytes’ beating. A video-based STFT method was developed to visualize the beating frequency during these manipulations. An in vitro co-culture method was developed to study the relationship between sympathetic neuronal firing and calcium dynamics in cardiomyocytes. In vivo, electrocardiograph (ECG) measurements showed that Clozapine N-oxide (CNO) caused heart rates increasement in cTnT-hM3Dq virus injected mouse. However, it had no impact on cTnT-hM4Di virus injected mouse. This study provides comprehensive methodologies for studying cardiomyocyte physiology and manipulating heart rates in vitro and in vivo.

Read PDF

Similar papers

Open access Aug 2026

Modeling sympathetic neuro-cardiac interactions in a hiPSC-based microphysiological system.

The cardiac autonomic nervous system is a key driver of various cardiac disorders and arrhythmias. However, investigating neuronal regulation of the human heart has proven difficult due to the limited availability of reliable experimental models. Here, we present a novel microphysiological system using a compartmentali...

Jean-Baptiste Reisqs, Y. Sleiman, Mohamed Boutjdir · 0 citations
Open access Sep 2026

A Biophysical Platform for Electromechanical Stimulation of Engineered Cardiac Tissues

Human engineered cardiac tissues (ECTs) provide an in vitro model for studying human cardiac physiology and drug responses, but their performance remains limited by culture systems that do not fully reproduce the heart’s electrical and mechanical environment. Electrical stimulation (ES) and mechanical stimulation (MS)...

Rui-Fen Hu, C. E. Varela, M. Karakan et al. · 0 citations
Open access Sep 2026

Force generation of cardiomyocytes in engineered environments

Cardiomyocyte contraction is essential for the pumping action of the heart and deteriorates after myocardial damage, either as a consequence of irreversible cardiomyocyte injury or stiffening of the extracellular matrix, a process described as fibrosis. Cell geometry and substrate stiffness not only influence sarcomere...

Mangalika Sinha, Ulrike Rölleke, Ruben Haag et al. · 0 citations
Review Sep 2026

[Revolutionizing physiology: advances in organ-on-a-chip technology].

To address the low predictability (92% clinical failure rate) and high costs associated with species differences in traditional animal testing, this research advocates for New Approach Methodologies (NAMs) in alignment with the US FDA Modernization Act 2.0. The central achievement presented is the development of a "hum...

Qiang Li, Ken Takahashi · 0 citations
Review Open access Sep 2026

Microfluidics in heart-on-a-Chip platforms for cardiovascular drug discovery and cardiotoxicity assessment.

Cardiovascular disease remains the leading cause of death worldwide. However, the limited translational fidelity of traditional preclinical models continues to constrain the development of safer and more effective therapies. Animal studies and static two-dimensional cultures only partially reproduce human cardiac physi...

Caner Dikyol, Alaa Alsaafin, David F. Bodenstein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.